Vaxelis; hexavalent vaccine (DTaP-IPV-Hib-HepB)
Jump to navigation
Jump to search
Indications
hexavalent vaccine for immunization against
children aged 6 weeks-4 years
Dosage
- 3-dose series at ages 2, 4, & 6 months
additional dose of pertussis vaccine required
Notes
- not be available until 2020
More general terms
References
- ↑ Sanofi Press Release December 26, 2018 FDA Approves VAXELIS <TM> Sanofi and MSD's Pediatric Hexavalent Combination Vaccine. http://hugin.info/152918/R/2230064/876179.pdf
- ↑ Oliver SE, Moore KL. Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants. MMWR Morb Mortal Wkly Rep 2020;69:136-139 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32027629 Free full text https://www.cdc.gov/mmwr/volumes/69/wr/mm6905a5.htm